Catalogo dei prodotti della ricerca

LAMBIASE, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.815
EU - Europa 2.736
AS - Asia 1.405
SA - Sud America 87
AF - Africa 25
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.089
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.746
IT - Italia 1.254
SG - Singapore 518
IN - India 436
CN - Cina 325
SE - Svezia 320
FI - Finlandia 278
DE - Germania 276
IE - Irlanda 138
RO - Romania 111
AR - Argentina 75
GB - Regno Unito 72
ID - Indonesia 72
CA - Canada 54
RU - Federazione Russa 54
UA - Ucraina 46
BG - Bulgaria 38
NL - Olanda 35
BE - Belgio 24
AU - Australia 18
FR - Francia 18
TW - Taiwan 13
MX - Messico 12
PL - Polonia 12
TG - Togo 11
ZA - Sudafrica 10
DK - Danimarca 9
ES - Italia 9
HK - Hong Kong 8
LT - Lituania 8
CH - Svizzera 7
HU - Ungheria 7
TR - Turchia 6
JP - Giappone 5
BR - Brasile 4
CL - Cile 4
GR - Grecia 4
IR - Iran 4
AT - Austria 3
CO - Colombia 3
LI - Liechtenstein 3
ME - Montenegro 3
SA - Arabia Saudita 3
EU - Europa 2
IQ - Iraq 2
MY - Malesia 2
PH - Filippine 2
PK - Pakistan 2
PT - Portogallo 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
AF - Afghanistan, Repubblica islamica di 1
BD - Bangladesh 1
BS - Bahamas 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
HR - Croazia 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
RS - Serbia 1
TH - Thailandia 1
UG - Uganda 1
VN - Vietnam 1
Totale 13.089
Salva come PNG Salva come JPEG
Città #
Fairfield 1.674
Woodbridge 727
Ashburn 702
Seattle 645
Houston 577
Wilmington 552
Cambridge 527
Chandler 526
Rome 465
Ann Arbor 365
Singapore 365
San Paolo di Civitate 285
Princeton 231
Lawrence 203
Dearborn 197
Plano 178
Boston 155
Beijing 143
Dublin 134
San Diego 98
Millbury 81
Federal 71
Jakarta 71
Santa Clara 69
Andover 59
New York 58
Milan 43
Helsinki 39
Sofia 38
Toronto 35
Phoenix 31
Bühl 25
Norwalk 25
Des Moines 23
Hefei 23
Kunming 22
Nanjing 22
Brussels 21
Grafing 20
Hyderabad 20
London 18
Mannheim 17
Adelaide 16
Bremen 15
Falls Church 14
Fremont 14
Boardman 13
Guangzhou 13
Los Angeles 13
Ottawa 12
Lappeenranta 11
Lomé 11
Nanchang 10
Verona 10
Pescara 9
Amsterdam 8
Falkenstein 8
Fasano 8
Jinan 8
Chang-hua 7
Redmond 7
Redwood City 7
Vejano 7
Viterbo 7
Dallas 6
Galdo 6
Genoa 6
Guidonia Montecelio 6
Horia 6
Muizenberg 6
Shanghai 6
Shenyang 6
Stockholm 6
Timisoara 6
Wuhan 6
Baotou 5
Campobasso 5
Chicago 5
Concord 5
Debrecen 5
Florence 5
Grassobbio 5
Grezzana 5
Indiana 5
Jacksonville 5
Pesaro 5
Prineville 5
Riano 5
San Mateo 5
Stratford-upon-Avon 5
Torino 5
Zhengzhou 5
Arnsberg 4
Artena 4
Athens 4
Buffalo 4
Chengdu 4
Duncan 4
Menlo Park 4
Mexico City 4
Totale 9.991
Salva come PNG Salva come JPEG
Nome #
Allergic conjunctivitis: current concepts on pathogenesis and management 144
Beta-amyloid peptide in tears: an early diagnostic marker of Alzheimer’s disease correlated with choroidal thickness 120
Involvement of the anterior segment of the eye in patients with mucopolysaccharidoses: a review of reported cases and updates on the latest diagnostic Instrumentation 115
Changes of NGF pathway in allergic rhinoconjunctivitis: a conjunctival allergen challenge study 113
Current and emerging treatment options for vernal keratoconjunctivitis 113
Behçet's disease: new insights into pathophysiology, clinical features and treatment options 111
Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study 109
Autoimmune vertigo: an update on vestibular disorders associated with autoimmune mechanisms 107
A two-Week, randomized, double-masked study to evaluate safety and efficacy of lubricin (150 μg/mL) eye drops versus sodium hyaluronate (HA) 0.18% eye drops (Vismed®) in patients with moderate dry eye disease 105
Retinal involvement and ocular findings in COVID-19 pneumonia patients 104
Ocular manifestations in Gorlin-Goltz syndrome 101
Near-infrared imaging: an in vivo, non-invasive diagnostic tool in neurofibromatosis type 1 98
Neuronavigational approach for orbital neurofibroma excision: a case report 97
Controversies in the management of neuromyelitis optica spectrum disorder 97
Diagnosis and management of neuromyelitis optica spectrum disorders - An update 95
Evaluation of IL8 pathway on the ocular surface: new insights in patients with ocular mucous membrane pemphigoid 91
Analysis of the pathogenic factors and management of dry eye in ocular surface disorders 90
Investigational drugs in dry eye disease 88
Hashimoto's thyroiditis: an update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation 88
Allergic chronic inflammation of the ocular surface in vernal keratoconjunctivitis 87
Autologous fibrin-cultured limbal stem cells permanently restore the corneal surface of patients with total limbal stem cell deficiency 85
Quality of life and neuropsychiatric disorders in patients with Graves’ orbitopathy: current concepts 84
Unusual case of angle closure glaucoma in a patient with neurofibromatosis type 1 83
In vivo antivascular endothelial growth factor treatment induces corneal endothelium apoptosis in rabbits through changes in p75NTR-proNGF pathway 83
A closer look at nerve growth factor: From biology to clinical trials in ophthalmology 82
Surgical management of concomitant ptosis and cicatricial entropion in a patient with ocular cicatricial pemphigoid 80
An update on intravitreal implants in use for eye disorders 79
Altered nerve growth factor level in the optic nerve of patients affected by multiple sclerosis 78
Prospective, multicenter demographic and epidemiological study on vernal keratoconjunctivitis: a glimpse of ocular surface in Italian population 78
Cenegermin for the treatment of neurotrophic keratitis 78
Biological parameters determining the clinical outcome of autologous cultures of limbal stem cells 78
Phase I trial of recombinant human nerve growth factor for neurotrophic keratitis 77
Anti-inflammatory and healing properties of nerve growth factor in immune corneal ulcers with stromal melting 75
Eye drop emulsion containing 0.1% cyclosporin (1 mg/mL) for the treatment of severe vernal keratoconjunctivitis: an evidence-based review and place in therapy 75
Diabetic retinopathy, oxidative stress and sirtuins: an in depth look in enzymatic patterns and new therapeutic horizons 75
NGF modulates trkANGFR/p75NTR in αsMA-expressing conjunctival fibroblasts from human ocular cicatricial pemphigoid (OCP) 74
Nerve growth factor eye drops to treat glaucoma 73
Cocaine snorting may induce ocular surface damage through corneal sensitivity impairment 73
Pathophysiology of corneal dystrophies: from cellular genetic alteration to clinical findings 73
In vivo characterization of doxycycline effects on tear metalloproteinases in patients with chronic blepharitis 72
Autoimmune diseases and the anterior segment of the eye 72
Ophthalmic manifestation in neurofibromatosis type 2 71
Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma 71
Systematic review of randomized clinical trials on safety and efficacy of pharmacological and nonpharmacological treatments for retinitis pigmentosa 71
From discovery to approval of an advanced therapy medicinal product-containing stem cells, in the EU 71
Development and preliminary validation of a new screening questionnaire for identifying atopic children 71
Neurotrophic factors and corneal nerve regeneration 71
Management of patients with Graves' disease and orbital involvement: role of spectral domain optical coherence tomography 71
A review of the role of ultrasound biomicroscopy in glaucoma associated with rare diseases of the anterior segment 71
High myopic patients with and without foveoschisis: morphological and functional characteristics 71
Amniotic membrane transplantation associated with conjunctival peritomy in the management of Mooren's ulcer: a case report 71
X-linked dominant RPGR gene mutation in a familial Coats angiomatosis 71
Hyperosmolar conjunctival provocation for the evaluation of nonspecific hyperreactivity in healthy patients and patients with allergy 71
Childhood uveitic glaucoma: complex management in a fragile population 70
Atopic and vernal keratoconjunctivitis: a model for studying atopic disease 70
Clinical and cytological findings in limbal stem cell deficiency 69
Clinical grading of vernal keratoconjunctivitis 69
An unusual case of acute glaucoma in Sturge-Weber syndrome 69
Therapeutic approaches with intravitreal injections in geographic atrophy secondary to age-related macular degeneration: current drugs and potential molecules 69
Topical treatment with nerve growth factor for neurotrophic keratitis 69
Nerve growth factor eye drops improve visual acuity and electrofunctional activity in age-related macular degeneration: a case report 69
Effect of exogenous administration of nerve growth factor in the retina of rats with inherited retinitis pigmentosa 68
Rare diseases of the anterior segment of the eye: update on diagnosis and management 68
Allergy screening in a schoolchildren-based population 68
Clinical and Epidemiological Study on Tubercular Uveitis in a Tertiary Eye Care Centre in Italy 68
Alterations of tear neuromediators in dry eye disease 67
Ocular manifestations of Sturge–Weber syndrome: pathogenesis, diagnosis, and management 67
Allergy and infections: long-term improvement of vernal keratoconjunctivitis following viral conjunctivitis 66
Eye drop NGF administration promotes the recovery of chemically injured cholinergic neurons of adult mouse forebrain 66
Recombinant human nerve growth factor treatment promotes photoreceptor survival in the retinas of rats with retinitis pigmentosa 65
An androgen receptor-positive carcinoma of the lacrimal drainage system resembling salivary duct carcinoma: case report and review of the literature 65
Nasal expression of the vascular endothelial growth factor and its receptors is reduced by mepolizumab in chronic rhinosinusitis with nasal polyposis 65
Corneal changes in neurosurgically induced neurotrophic keratitis. 64
Nerve growth factor in Behçet's disease 64
Phase 2 randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitis 64
Topical treatment with nerve growth factor in an animal model of herpetic keratitis 64
Expression of Toll-like receptors in healthy and allergic conjunctiva 63
Allergic conjunctivitis 63
Preservative-free diclofenac sodium 0.1% for vernal keratoconjunctivitis 63
The topical application of nerve growth factor as a pharmacological tool for human corneal and skin ulcers 63
Clinical presentation and management of congenital ptosis 63
Nerve growth factor therapy for corneal disease 62
Neurotrophic factors and nerve growth factor in ocular allergy 62
A characteristic type of retinal microvascular abnormalities in a patient with neurofibromatosis type 1 62
CD34-positive cells in human umbilical cord blood express nerve growth factor and its specific receptor TrkA 61
Congenital corneal anesthesia and neurotrophic keratitis: diagnosis and management 61
Tear ferning test and pathological effects on ocular surface before and after topical cyclosporine in vernal keratoconjunctivitis patients 61
Topical treatment with nerve growth factor for corneal neurotrophic ulcers 60
Toll-like receptors in ocular surface diseases: overview and new findings 60
Multiple action agents and the eye: do they really stabilize mast cells? 60
Time-dependent nerve growth factor signaling changes in the rat retina during optic nerve crush-induced degeneration of retinal ganglion cells 60
Sex hormones in allergic conjunctivitis: altered levels of circulating androgens and estrogens in children and adolescents with vernal keratoconjunctivitis 60
Molecular and biochemical expression of TLRs in human amniotic membrane: a comparative study of fresh and cryopreserved specimens. 59
Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis 59
Evidence of pepsin-related ocular surface damage and dry eye (PROD syndrome) in patients with laryngopharyngeal reflux 59
Systematic review of randomised clinical trials on topical ciclosporin A for the treatment of dry eye disease. 59
Tailored approach to the treatment of vernal keratoconjunctivitis 58
Location and clonal analysis of stem cells and their differentiated progeny in the human ocular surface 58
The complex relationship between diabetic retinopathy and high-mobility group box: a review of molecular pathways and therapeutic strategies 58
MUC5AC overexpression in tear film of neonates 58
Totale 7.547
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.382
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.382
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.617 0 0 0 0 332 490 505 391 389 215 194 101
2020/20211.265 132 119 70 126 52 45 111 72 149 191 154 44
2021/20222.386 20 137 252 159 270 86 72 263 186 178 323 440
2022/20232.318 435 647 130 207 161 151 55 171 212 24 81 44
2023/20241.215 108 127 55 114 91 98 56 69 21 211 125 140
2024/2025821 109 147 215 213 137 0 0 0 0 0 0 0
Totale 13.907